Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Bio-Path Holdings (BPTH)

Bio-Path Holdings (BPTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Bio-Path Holdings Provides 2025 Clinical and Operational Update GlobeNewswire - Fri Jan 10, 6:00AM CST

BPTH : 0.9500 (-2.92%)
White tablets on pink background by Jose Antonio Luque Olemedo via iStock
Is This Penny Stock a Buy After a 180% Rally? Barchart - Sun Dec 29, 2024

Bio-Path Holdings surged 180% on promising obesity drug results. Discover why this penny stock's pivot from cancer treatments and Nasdaq delisting challenges could matter for investors.

BPTH : 0.9500 (-2.92%)
Bio-Path Holdings, Inc. Reports Promising Preclinical Results for BP1001-A as a Potential Treatment for Obesity and Type 2 Diabetes Quiver Quantitative, Inc. - Thu Dec 19, 2024

Bio-Path Holdings reports BP1001-A shows promise for treating obesity and Type 2 diabetes by enhancing insulin sensitivity.Quiver AI SummaryBio-Path Holdings, Inc. announced promising preclinical results...

BPTH : 0.9500 (-2.92%)
Bio-Path Rockets To 4-Month High As Obesity Drug Shows Promise For Diabetes: Retail In Celebration Mode Stocktwits - Thu Dec 19, 2024

The company said it has initiated animal studies to further confirm the drug’s efficacy, with plans to launch a first-in-human Phase 1 trial in 2025.

VXF : 189.23 (-1.54%)
BPTH : 0.9500 (-2.92%)
Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients Enhances Insulin Sensitivity GlobeNewswire - Thu Dec 19, 2024

BPTH : 0.9500 (-2.92%)
Bio-Path Holdings, Inc. Shift Focus to BP1001-A Development for Type 2 Diabetes and Discontinue BP1002 Enrollment Due to Challenges Quiver Quantitative, Inc. - Wed Dec 11, 2024

Bio-Path Holdings reallocates resources to BP1001-A for obesity treatment, discontinuing BP1002 lymphoma study due to enrollment challenges.Quiver AI SummaryBio-Path Holdings, Inc. has announced plans...

BPTH : 0.9500 (-2.92%)
Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients GlobeNewswire - Wed Dec 11, 2024

BPTH : 0.9500 (-2.92%)
Bio-Path Holdings, Inc. Expands DNAbilize® Technology to Obesity Treatment, Reveals Third Quarter Financial Results Quiver Quantitative, Inc. - Fri Nov 15, 2024

Bio-Path Holdings reports Q3 2024 results, initiating obesity program, advancing oncology trials, and closing a $4M private placement.Quiver AI SummaryBio-Path Holdings, Inc. has expanded its DNAbilize®...

BPTH : 0.9500 (-2.92%)
Bio-Path: Q3 Earnings Snapshot AP - Fri Nov 15, 2024

Bio-Path: Q3 Earnings Snapshot

BPTH : 0.9500 (-2.92%)
Bio-Path Holdings Reports Third Quarter 2024 Financial Results GlobeNewswire - Fri Nov 15, 2024

BPTH : 0.9500 (-2.92%)

Barchart Exclusives

Williams-Sonoma’s Unusual Options Activity Provides Bullish Investors With an Excellent Income Opportunity Barchart - 6 minutes ago
There were 1,403 unusually active options in Wednesday's trading. Williams-Sonoma only had one, but it provides investors with an excellent income opportunity over the next 30 days. Here's how. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot